425: Strive and Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. are moving forward with a proposed business combination, as detailed in a recent SEC filing.

Summary

• Strive, Inc. and Semler Scientific, Inc. are engaged in a proposed business combination.
• The communication, a Form 425 filing, was reposted on X.com by Ben Werkman, Chief Investment Officer of Strive, Inc., on November 10, 2025.
• The filing emphasizes cautionary statements regarding forward-looking statements related to the proposed transaction, including expected strategic and financial benefits, timing, and integration.
• It outlines various risks and uncertainties that could cause actual results to differ materially from anticipated outcomes.
• Investors and stockholders are urged to read the Registration Statement on Form S-4, which includes an Information Statement/Proxy Statement/Prospectus, and other relevant documents filed with the SEC before making voting or investment decisions.

Sentiment

Score: 5

Explanation: The filing is a procedural document for a proposed merger, heavily focused on cautionary statements and risks. While the underlying event (a merger) can be positive, the document itself is neutral to slightly negative in tone due to the extensive risk disclosures, which is standard for such filings.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.

Negatives

• The proposed transaction may not close as expected or at all due to unfulfilled conditions.
• Anticipated benefits, including cost savings and strategic gains, may not be realized.
• Integration of the two companies could be more difficult, time-consuming, or costly than expected.
• The transaction may be more expensive or take longer to complete than anticipated.
• Management's attention may be diverted from ongoing business operations and opportunities.
• Strive's issuance of additional shares of Class A common stock in connection with the transaction will cause dilution.
• Potential adverse reactions from customers or changes to business/employee relationships may occur.
• Changes in Strive's or Semler Scientific's share price may occur before closing.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The filing contains forward-looking statements regarding the outlook and expectations of Strive and Semler Scientific with respect to the proposed transaction. These include anticipated strategic and financial benefits, the expected impact on the combined company's future financial performance, the timing of the closing, and the ability to successfully integrate the combined businesses. However, these statements are subject to significant risks and uncertainties.

Management Comments

• Ben Werkman, Chief Investment Officer of Strive, Inc., reposted the communication on X.com on November 10, 2025, in connection with the proposed business combination.

Industry Context

This filing is a procedural communication related to a specific merger and does not provide broader industry analysis or context. It focuses on the legal and risk aspects of the proposed business combination between Strive and Semler Scientific.

Stakeholder Impact

• Shareholders of Semler Scientific will be asked to vote on the proposed transaction.
• Strive's shareholders will experience dilution due to the issuance of additional Class A common stock.
• Customers and employees of both companies may have adverse reactions or changes to their relationships due to the announcement or completion of the transaction.

Next Steps

• Semler Scientific stockholders will need to approve the proposed transaction.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders.
• Strive and Semler Scientific may file other relevant documents concerning the proposed transaction with the SEC.
• The combined businesses will need to be successfully integrated post-closing.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., merger, business combination, SEC filing, Form 425, acquisition, forward-looking statements, Bitcoin, digital assets